2023
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists
Harms P, Frankel T, Moutafi M, Rao A, Rimm D, Taube J, Thomas D, Chan M, Pantanowitz L. Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists. Modern Pathology 2023, 36: 100197. PMID: 37105494, DOI: 10.1016/j.modpat.2023.100197.Peer-Reviewed Original ResearchConceptsDigital spatial profilingMost clinical laboratoriesTumor microenvironmentImmunofluorescence/immunohistochemistryImmuno-oncology researchDiagnostic practiceClinical laboratoriesRoutine diagnostic useAntitumor immunityAdvanced cancerImmune populationsMultiplex stainingEosin stainingIHC stainsPractical updateClinical diagnostic practiceMultiplex immunohistochemistrySingle biomarkerImmunohistochemistryMultiplexed immunohistochemistryStandardized protocolChromogenic immunohistochemistryDiagnostic useMultiple biomarkersSerial sectionsMagnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes
Tinaz S. Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes. Frontiers In Neurology 2023, 14: 1082060. PMID: 36816565, PMCID: PMC9932598, DOI: 10.3389/fneur.2023.1082060.Peer-Reviewed Original ResearchAtypical parkinsonian syndromesParkinsonian syndromesParkinson's diseaseIdiopathic Parkinson's diseaseDisease courseClinical manifestationsDifferential diagnosisTimely diagnosisModalities aidDiagnostic criteriaClinical practiceMRI toolsMagnetic resonance imaging (MRI) technologyNuclear imagingDiagnosisDiagnostic useSyndromeMRI modalitiesDiseaseDiagnostic purposesModalities
2014
Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreas Divisum
Rustagi T, Njei B. Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreas Divisum. Pancreas 2014, 43: 823-828. PMID: 24743381, DOI: 10.1097/mpa.0000000000000143.Peer-Reviewed Original ResearchConceptsMagnetic resonance cholangiopancreatographyDiagnosis of pancreas divisumSecretin-enhanced magnetic resonance cholangiopancreatographyPancreas divisumS-MRCPHighest overall diagnostic performanceQuantitative receiver operating characteristicDerSimonian-Laird random-effects modelPooled diagnostic odds ratioComprehensive search of PubMedDiagnostic odds ratioOverall diagnostic performanceSearch of PubMedReceiver Operating CharacteristicRandom-effects modelPooled sensitivityDiagnostic performanceDiagnostic accuracyCriterion standardOdds ratioSecretin enhancementCochrane LibraryDivisumDiagnostic useFunnel plot
2013
Tissue microarrays: leaping the gap between research and clinical adoption
Gustavson MD, Rimm DL, Dolled-Filhart M. Tissue microarrays: leaping the gap between research and clinical adoption. Personalized Medicine 2013, 10: 441-451. PMID: 29758838, DOI: 10.2217/pme.13.42.Peer-Reviewed Original ResearchTissue microarrayClinical laboratory settingUse of TMAsRoutine diagnostic purposesAdvanced imagingClinical settingPatient samplesDiagnostic useTissue assessmentTranslational research settingsExpression assessmentClinical research applicationsBiomarker analysisDiagnostic assaysDiagnostic purposesResearch settingsClinical adoption
2009
Mitochondrial DNA analysis by multiplex denaturing high-performance liquid chromatography and selective sequencing in pediatric patients with cardiomyopathy
Schrijver I, Pique LM, Traynis I, Scharfe C, Sehnert AJ. Mitochondrial DNA analysis by multiplex denaturing high-performance liquid chromatography and selective sequencing in pediatric patients with cardiomyopathy. Genetics In Medicine 2009, 11: 118-126. PMID: 19265752, DOI: 10.1097/gim.0b013e318190356b.Peer-Reviewed Original ResearchConceptsHereditary optic neuropathyPediatric patientsWorse clinical symptomsHigh-performance liquid chromatographyDNA testingLeber's hereditary optic neuropathyIndividual sequence changesMutation analysisNovel heteroplasmic mutationClinical diagnostic useIdiopathic cardiomyopathyRare causeClinical symptomsOptic neuropathyDefinitive diagnosisPediatric cardiomyopathyAdditional functional parametersMultisystemic diseaseCardiomyopathyPathogenic changesUncertain pathogenicityLiquid chromatographyPatientsRespiratory chain activityDiagnostic useDiagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma
Ahmad I, Iyer A, Marginean CE, Yeh MM, Ferrell L, Qin L, Bifulco CB, Jain D. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma. Human Pathology 2009, 40: 726-734. PMID: 19157505, DOI: 10.1016/j.humpath.2008.10.018.Peer-Reviewed Original ResearchConceptsTelangiectatic focal nodular hyperplasiaFocal nodular hyperplasia casesFocal nodular hyperplasiaNeuronal cell adhesion moleculeHepatic adenomaNodular hyperplasiaCytokeratin 7Cytokeratin 19Hyperplasia casesNeedle biopsyCell adhesion moleculeBile ductAdhesion moleculesCD34 stainCytokeratin 7 stainingCorresponding resection specimensDiagnostic useParaffin-embedded sectionsDistinct staining patternsProspective studyResected specimensHistologic featuresResection specimenResection specimensCorresponding resections
2002
Cytokines and Human Type 1 Diabetes
Kent S, Viglietta V, Hafler D. Cytokines and Human Type 1 Diabetes. 2002, 295-316. DOI: 10.1007/978-1-59259-129-9_12.Peer-Reviewed Original ResearchHuman leukocyte antigenGlutamic acid decarboxylaseType 1 diabetesContribution of human leukocyte antigenHuman type 1 diabetesPresence of autoantibodiesIslet cell antigensGenetic associationCytokine-mediated eventsLeukocyte antigenDisease developmentHLA-DQ8Cell antigensMouse modelDisease onsetAcid decarboxylaseDiagnostic useMetabolic measuresAntigenWell-characterizedDiseaseAutoantibodiesRisk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply